Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.86 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.86 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.82 |
| ▸ | MAPT | P10636 | 4/20 | 0.75 |
| ▸ | MAOB | P27338 | 4/20 | 0.75 |
| ▸ | MAOA | P21397 | 1/20 | 0.75 |
| ▸ | RECQL | P46063 | 2/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.69 |
| ▸ | USP2 | O75604 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.69 |
| ▸ | POLB | P06746 | 1/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.69 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.69 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.69 |
| ▸ | F3 | P13726 | 2/20 | 0.68 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.68 |
| ▸ | TNFRSF1A | P19438 | 2/20 | 0.66 |
| ▸ | P4HB | P07237 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1659833 | 1.00 | ESR1 (0.86) | ESR1ESR2CYP1B1MAPTMAOB | |
| SCHEMBL17694974 | 0.94 | ESR1 (0.77) | ESR1ESR2CYP1B1MAPTMAOB | |
| SCHEMBL25212485 | 0.93 | CYP1B1 (0.77) | ESR1ESR2CYP1B1MAPTMAOB | |
| SCHEMBL25203783 | 0.93 | CYP1B1 (0.77) | ESR1ESR2CYP1B1MAPTMAOB | |
| SCHEMBL3268064 | 0.93 | CYP1B1 (0.77) | ESR1ESR2CYP1B1MAPTMAOB | |
| SCHEMBL25200521 | 0.93 | CYP1B1 (0.77) | ESR1ESR2CYP1B1MAPTMAOB | |
| SCHEMBL25223617 | 0.93 | CYP1B1 (0.77) | ESR1ESR2CYP1B1MAPTMAOB | |
| SCHEMBL25221605 | 0.93 | ESR1 (1.00) | ESR1ESR2CYP1B1MAPTMAOB | |
| SCHEMBL25221606 | 0.93 | ESR1 (1.00) | ESR1ESR2CYP1B1MAPTMAOB | |
| SCHEMBL25195374 | 0.93 | CYP1B1 (0.77) | ESR1ESR2CYP1B1MAPTMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118894756-A | Deoxidization and reduction method for alpha, beta unsaturated ketone | 温州医科大学 | 2024-11-05 | — | — | CN | disclosed |
| US-20240334821-A1 | Electroluminescent Device | UDC IRELAND LTD (IE) | 2024-10-03 | — | — | US | disclosed |
| US-11968893-B2 | Electroluminescent device | UDC IRELAND LIMITED (IE) | 2024-04-23 | — | — | US | disclosed |
| US-11661407-B2 | Process for the preparation of pyrylium salts | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2023-05-30 | — | — | US | disclosed |
| US-20220216422-A1 | Electroluminescent Device | UDC IRELAND LTD (IE) | 2022-07-07 | — | — | US | disclosed |
| US-20220216422-A1 | Electroluminescent Device | UDC IRELAND LTD (IE) | 2022-07-07 | — | — | US | disclosed |
| US-11289658-B2 | Electroluminescent device | UDC IRELAND LIMITED (IE) | 2022-03-29 | — | — | US | disclosed |
| US-20210087158-A1 | A PROCESS FOR THE PREPARATION OF PYRYLIUM SALTS | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2021-03-25 | — | — | US | disclosed |
| US-10941114-B2 | Small molecule lipid II inhibitors | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2021-03-09 | — | — | US | disclosed |
| US-10941114-B2 | Small molecule lipid II inhibitors | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2021-03-09 | — | — | US | disclosed |
| EP-2305772-A1 | COMPOSITION CONTAINING A METAL COMPLEX AND ORGANIC COMPOUND, AND LIGHT EMITTING ELEMENT USING SAID COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2011-04-06 | — | — | EP | disclosed |
| EP-2305772-A1 | COMPOSITION CONTAINING A METAL COMPLEX AND ORGANIC COMPOUND, AND LIGHT EMITTING ELEMENT USING SAID COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2011-04-06 | — | — | EP | disclosed |
| US-20100240892-A1 | ELECTROLUMINESCENT DEVICE | SCHAEFER THOMAS | 2010-09-23 | — | — | US | disclosed |
| US-20100240892-A1 | ELECTROLUMINESCENT DEVICE | SCHAEFER THOMAS | 2010-09-23 | — | — | US | disclosed |
| US-20100240892-A1 | ELECTROLUMINESCENT DEVICE | SCHAEFER THOMAS | 2010-09-23 | — | — | US | disclosed |
| US-20100039026-A1 | Organic light emitting diode employing luminescent efficiency improvement layer | SAMSUNG DISPLAY CO., LTD. (KR) | 2010-02-18 | — | — | US | disclosed |
| US-20100039026-A1 | Organic light emitting diode employing luminescent efficiency improvement layer | SAMSUNG DISPLAY CO., LTD. (KR) | 2010-02-18 | — | — | US | disclosed |
| WO-2010006890-A1 | AZAPYRENES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2010-01-21 | — | — | WO | disclosed |
| EP-1556360-B1 | ELECTROLUMINESCENT DEVICE | CIBA SC HOLDING AG (CH) | 2008-01-23 | — | — | EP | disclosed |
| US-20060041126-A1 | Blue emitting, durable, organoelectroluminescent layers containing pyrimidine moieties; full color displays; light emission efficiency and brightness | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060041126-A1 | Blue emitting, durable, organoelectroluminescent layers containing pyrimidine moieties; full color displays; light emission efficiency and brightness | AXL, TK1, TYMP | ESR1 919/4885ESR2 1867/4885CYP1B1 1587/4885 |
| US-20240334821-A1 | Electroluminescent Device | PNPO, ODC1, AXL | ESR1 805/4885ESR2 1217/4885CYP1B1 2432/4885 |
| US-20210087158-A1 | A PROCESS FOR THE PREPARATION OF PYRYLIUM SALTS | IPO5, SF3B5, CYP4F11 | ESR1 4636/4885ESR2 3986/4885CYP1B1 110/4885 |
| US-10941114-B2 | Small molecule lipid II inhibitors | DBI, FABP2, SREBF2 | ESR1 3312/4885ESR2 1772/4885CYP1B1 1219/4885 |
| US-11289658-B2 | Electroluminescent device | PNPO, ODC1, AXL | ESR1 805/4885ESR2 1217/4885CYP1B1 2432/4885 |
| US-20220216422-A1 | Electroluminescent Device | PNPO, ODC1, AXL | ESR1 805/4885ESR2 1217/4885CYP1B1 2432/4885 |
| US-11661407-B2 | Process for the preparation of pyrylium salts | SF3B5, IPO5, CYP4F11 | ESR1 4676/4885ESR2 3917/4885CYP1B1 139/4885 |
| US-11968893-B2 | Electroluminescent device | PNPO, ODC1, AXL | ESR1 805/4885ESR2 1217/4885CYP1B1 2432/4885 |
| US-20100240892-A1 | ELECTROLUMINESCENT DEVICE | PNPO, ODC1, AXL | ESR1 805/4885ESR2 1217/4885CYP1B1 2432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.